Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 145

Results For "API"

2941 News Found

IIT Kanpur signs MoU with Sensa Core for technology transfer of novel strip to analyse bilirubin in human blood
News | September 13, 2023

IIT Kanpur signs MoU with Sensa Core for technology transfer of novel strip to analyse bilirubin in human blood

The non-enzymatic electrochemical sensing strip can simultaneously detect the direct and total bilirubin in a single drop of blood, and provide the concentrations within a minute


Gufic Biosciences receives TGA Australia and ANVISA Brazil approval for Parecoxib 40mg injection
Drug Approval | September 12, 2023

Gufic Biosciences receives TGA Australia and ANVISA Brazil approval for Parecoxib 40mg injection

Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management


Indian pharma industry to witness 8-10% revenue growth in fiscal 2024: CRISIL
News | September 12, 2023

Indian pharma industry to witness 8-10% revenue growth in fiscal 2024: CRISIL

Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable


Pachouli Aesthetics & Wellness launches its Faridabad Clinic
News | September 08, 2023

Pachouli Aesthetics & Wellness launches its Faridabad Clinic

Marking a significant milestone in its commitment to holistic wellness


Defending Public Health: Strategies to safeguard pharmaceutical quality: Raheel Shah, Business Development Director, BDR Pharmaceuticals
Opinion | September 08, 2023

Defending Public Health: Strategies to safeguard pharmaceutical quality: Raheel Shah, Business Development Director, BDR Pharmaceuticals

This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards


Biocon Biologics completes integration of Viatris Biosimilars’ business in North America
News | September 07, 2023

Biocon Biologics completes integration of Viatris Biosimilars’ business in North America

Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris


NTPC partners with Apollo Hospitals to introduce Tele-Emergency and Tele-ICU Services across its 9 plants locations
News | September 07, 2023

NTPC partners with Apollo Hospitals to introduce Tele-Emergency and Tele-ICU Services across its 9 plants locations

These plant locations include Ramagundam, Talcher Kaniha, Korba, Vindhyachal, Dadri, Barh, Solapur, North Karanpura, and Mauda


Apollo Hospitals joins MediSage to host Uro-Oncology symposium
News | September 07, 2023

Apollo Hospitals joins MediSage to host Uro-Oncology symposium

Our collaboration with MediSage to present 'Current Approaches to Uro-Oncology' embodies a crucial stride towards comprehensive cancer care


New tools of diagnosis and therapeutic medicine require holistic approach for desired optimum results, says Dr Jinetdar Singh
Policy | September 06, 2023

New tools of diagnosis and therapeutic medicine require holistic approach for desired optimum results, says Dr Jinetdar Singh

Dr Jitendra Singh launches API Chapter of AFMC, Pune; inaugurates the first annual conference of API-AFMS Continuing Medical Education (CME) on “Emerging trends in the practice of Medicine”


Amgen olpasiran may fill critical treatment gap in lowering Lp(a): GlobalData
News | September 06, 2023

Amgen olpasiran may fill critical treatment gap in lowering Lp(a): GlobalData

This study showed that patients taking 75mg of Olpasiran previously every 12 weeks presented a 40–50% reduction in LP(a)